Inventiva (IVA) to Release Earnings on Wednesday

Inventiva (NASDAQ:IVA) is projected to announce its earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.43) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Inventiva Stock Performance

NASDAQ IVA opened at $2.92 on Tuesday. Inventiva has a one year low of $1.53 and a one year high of $3.98. The firm’s fifty day moving average is $2.64 and its two-hundred day moving average is $2.47.

Analysts Set New Price Targets

IVA has been the subject of several analyst reports. TD Cowen initiated coverage on Inventiva in a research note on Friday, February 21st. They set a “buy” rating and a $10.00 price objective for the company. HC Wainwright restated a “buy” rating and set a $13.00 price target on shares of Inventiva in a research note on Thursday, January 30th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $12.60.

Inventiva Company Profile

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.